CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

交易 Lexicon - LXRX CFD

2.72
1.49%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.05
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.025457%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.003235%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

Lexicon Pharmaceuticals Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 2.68
开仓* 2.68
1 年变化* 54.02%
日范围* 2.65 - 2.75
52 周范围 1.31-3.79
平均交易量(10 天) 5.05M
平均交易量(3 个月) 29.81M
市值 520.35M
市盈率 -100.00K
流通股 244.85M
收入 126.00K
EPS -0.63
股息(收益率 %) N/A
贝塔 1.27
下一个财报发布日期 Jul 31, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平仓 Change Change (%) 開倉 High Low
Jun 2, 2023 2.72 -0.03 -1.09% 2.75 2.77 2.64
Jun 1, 2023 2.68 0.00 0.00% 2.68 2.70 2.54
May 31, 2023 3.27 0.39 13.54% 2.88 3.39 2.87
May 30, 2023 2.86 -0.52 -15.38% 3.38 3.43 2.65
May 26, 2023 3.14 0.12 3.97% 3.02 3.20 2.90
May 25, 2023 2.86 -0.17 -5.61% 3.03 3.03 2.83
May 24, 2023 2.98 -0.04 -1.32% 3.02 3.02 2.94
May 23, 2023 3.02 -0.16 -5.03% 3.18 3.27 3.02
May 22, 2023 3.17 0.10 3.26% 3.07 3.27 3.03
May 19, 2023 2.97 0.04 1.37% 2.93 3.00 2.86
May 18, 2023 2.86 -0.04 -1.38% 2.90 2.91 2.76
May 17, 2023 2.89 -0.04 -1.37% 2.93 2.94 2.84
May 16, 2023 2.90 -0.03 -1.02% 2.93 2.95 2.81
May 15, 2023 2.94 0.06 2.08% 2.88 3.01 2.84
May 12, 2023 2.83 -0.29 -9.29% 3.12 3.16 2.81
May 11, 2023 3.10 0.06 1.97% 3.04 3.17 2.98
May 10, 2023 3.03 -0.13 -4.11% 3.16 3.16 2.91
May 9, 2023 3.00 -0.24 -7.41% 3.24 3.24 2.96
May 8, 2023 3.23 -0.27 -7.71% 3.50 3.53 3.20
May 5, 2023 3.45 0.36 11.65% 3.09 3.75 3.05

Lexicon Events

时间(协调世界时) (UTC) 国家/地区 事件
Monday, July 31, 2023

时间(协调世界时) (UTC)

10:59

国家/地区

US

事件

Q2 2023 Lexicon Pharmaceuticals Inc Earnings Release
Q2 2023 Lexicon Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Tuesday, November 7, 2023

时间(协调世界时) (UTC)

10:59

国家/地区

US

事件

Q3 2023 Lexicon Pharmaceuticals Inc Earnings Release
Q3 2023 Lexicon Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 0.139 0.298 23.995 322.073 63.209
收入 0.139 0.298 23.995 322.073 63.209
收入成本,共计 0 0 1.929 3.231 2.491
毛利 0.139 0.298 22.066 318.842 60.718
总营业费用 100.899 87.388 70.792 180.628 166.488
销售/一般/行政费用,总计 48.083 32.342 47.23 56.835 63.754
研究与开发 52.816 55.046 153.621 91.924 100.243
Other Operating Expenses, Total 0 0
营业收入 -100.76 -87.09 -46.797 141.445 -103.279
利息收入(费用),非经营净值 -2.78 -0.802 -14.544 -20.676 -20.777
其他,净值 1.596 0.134 2.767 3.35 3.508
税前净收入 -101.944 -87.758 -58.574 124.119 -120.548
税后净收入 -101.944 -87.758 -58.574 130.133 -120.548
未计算非常项目前的净收益 -101.944 -87.758 -58.574 130.133 -120.548
净收入 -101.944 -87.758 -58.574 130.133 -120.548
普通股股东可获收益 (不含非经常性项目) -101.944 -87.758 -58.574 130.133 -120.548
普通股股东可获收益 (含非經常性項目) -101.944 -87.758 -58.574 130.133 -120.548
摊薄净收入 -101.944 -87.758 -58.574 130.133 -120.548
摊薄后加权平均股 165.733 145.652 110.841 116.747 105.83
扣除特别项目的每股摊薄盈利 -0.61511 -0.60252 -0.52845 1.11466 -1.13907
每股正常摊薄盈利 -0.61511 -0.60252 -1.71924 1.2741 -1.13907
非常规项目总计 0
异常费用(收入) 0 0 -131.988 28.638
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
总收入 0.024 0.028 0.039 0.035 0.037
收入 0.024 0.028 0.039 0.035 0.037
收入成本,共计
毛利
总营业费用 31.166 30.306 23.134 24.042 23.417
销售/一般/行政费用,总计 19.14 16.329 12.577 10.686 8.491
研究与开发 12.026 13.977 10.557 13.356 14.926
营业收入 -31.142 -30.278 -23.095 -24.007 -23.38
利息收入(费用),非经营净值 -1.821 -1.103 -0.864 -0.703 -0.11
其他,净值 1.029 0.887 0.572 0.123 0.014
税前净收入 -31.934 -30.494 -23.387 -24.587 -23.476
税后净收入 -31.934 -30.494 -23.387 -24.587 -23.476
未计算非常项目前的净收益 -31.934 -30.494 -23.387 -24.587 -23.476
净收入 -31.934 -30.494 -23.387 -24.587 -23.476
普通股股东可获收益 (不含非经常性项目) -31.934 -30.494 -23.387 -24.587 -23.476
普通股股东可获收益 (含非經常性項目) -31.934 -30.494 -23.387 -24.587 -23.476
摊薄净收入 -31.934 -30.494 -23.387 -24.587 -23.476
摊薄后加权平均股 189.014 188.98 174.904 149.616 149.15
扣除特别项目的每股摊薄盈利 -0.16895 -0.16136 -0.13371 -0.16433 -0.1574
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.16895 -0.16136 -0.13371 -0.16433 -0.1574
异常费用(收入) 0
  • 年度
  • 每季度
2022 2021 2020 2019 2018
流动资产总额 140.866 88.921 157.719 337.754 173.324
现金和短期投资 138.357 86.743 152.275 271.659 160.052
现金等价物 46.345 64.065 126.263 36.112 80.386
短期投资 92.012 22.678 26.012 235.547 79.666
应收账款总额,净额 0.028 0.014 0.395 56.532 5.924
Accounts Receivable - Trade, Net 0.028 0.014 0.395 56.532 5.924
Prepaid Expenses 2.481 2.164 5.049 5.32 2.668
Total Assets 194.299 136.909 203.788 417.715 284.136
Property/Plant/Equipment, Total - Net 4.371 3.476 1.495 15.747 15.865
Property/Plant/Equipment, Total - Gross 8.355 8.329 7.31 77.488 75.871
Accumulated Depreciation, Total -3.984 -4.853 -5.815 -61.741 -60.006
Goodwill, Net 44.543 44.543 44.543 44.543 44.543
Intangibles, Net 0 19.716 50.119
Other Long Term Assets, Total 4.519 -0.031 0.031 -0.045 0.285
Total Current Liabilities 23.172 22.124 46.806 65.341 36.751
Accounts Payable 10.395 9.152 5.469 12.178 17.759
Accrued Expenses 12.373 10.469 29.691 42.151 14.482
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 11.646 11.012 1.115
Other Current Liabilities, Total 0.404 2.503 0 3.395
Total Liabilities 77.175 23.314 47.417 300.614 310.541
Total Long Term Debt 48.579 0 0 234.171 243.887
Long Term Debt 48.579 0 234.171 243.887
Deferred Income Tax 0 6.014
Other Liabilities, Total 5.424 1.19 0.611 1.102 23.889
Total Equity 117.124 113.595 156.371 117.101 -26.405
Common Stock 0.189 0.15 0.142 0.106 0.106
Additional Paid-In Capital 1709.14 1608.75 1561.1 1462.17 1447.95
Retained Earnings (Accumulated Deficit) -1589.72 -1487.78 -1400.02 -1341.44 -1471.58
Treasury Stock - Common -2.061 -7.518 -4.843 -3.817 -2.876
Other Equity, Total -0.428 -0.01 -0.006 0.084 -0.012
Total Liabilities & Shareholders’ Equity 194.299 136.909 203.788 417.715 284.136
Total Common Shares Outstanding 188.726 148.917 141.496 106.272 105.926
Total Inventory 0 4.243 4.68
Redeemable Preferred Stock 0 0 0 0 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
流动资产总额 109.546 140.866 139.063 64.898 88.431
现金和短期投资 105.937 138.357 136.203 61.968 86.502
现金等价物 26.001 46.345 18.834 21.45 59.52
短期投资 79.936 92.012 117.369 40.518 26.982
应收账款总额,净额 0.261 0.028 0.039 0.034 0.037
Accounts Receivable - Trade, Net 0.261 0.028 0.039 0.034 0.037
Prepaid Expenses 3.348 2.481 2.821 2.896 1.892
Total Assets 162.716 194.299 191.685 112.325 136.178
Property/Plant/Equipment, Total - Net 8.627 4.371 8.032 2.835 3.242
Property/Plant/Equipment, Total - Gross 6.303 8.355 6.109 6.105 6.104
Accumulated Depreciation, Total -4.096 -3.984 -5.177 -5.07 -4.962
Goodwill, Net 44.543 44.543 44.543 44.543 44.543
Other Long Term Assets, Total 4.519 0.047 0.049 -0.038
Total Current Liabilities 20.371 23.172 18.445 16.862 18.905
Accounts Payable 10.311 10.395 9.427 7.347 9.321
Accrued Expenses 9.576 12.373 8.299 9.038 8.864
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases
Total Liabilities 74.67 77.175 47.667 41.495 43.48
Total Long Term Debt 48.845 48.579 23.784 23.631 23.477
Other Liabilities, Total 5.454 5.424 5.438 1.002 1.098
Total Equity 88.046 117.124 144.018 70.83 92.698
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.19 0.189 0.189 0.15 0.15
Additional Paid-In Capital 1712.56 1709.14 1705.61 1608.73 1605.9
Retained Earnings (Accumulated Deficit) -1621.65 -1589.72 -1559.23 -1535.84 -1511.25
Treasury Stock - Common -2.885 -2.061 -2.061 -2.061 -2.061
Other Equity, Total -0.163 -0.428 -0.491 -0.15 -0.037
Total Liabilities & Shareholders’ Equity 162.716 194.299 191.685 112.325 136.178
Total Common Shares Outstanding 189.562 188.726 188.726 149.626 149.594
Other Current Liabilities, Total 0.484 0.404 0.719 0.477 0.72
Long Term Debt 48.845 48.579 23.784 23.631 23.477
  • 年度
  • 每季度
2022 2021 2020 2019 2018
净收入/起跑线 -101.944 -87.758 -58.574 130.133 -120.548
经营活动产生的现金 -88.851 -87.017 -142.969 113.807 -148.607
经营活动产生的现金 0.427 0.292 2.934 3.654 3.683
Deferred Taxes 0 0 -6.014 0
非现金物品 12.264 10.68 -118.408 44.321 13.032
已付现金利息 2.289 0.799 17.353 19.211 16.465
营运资金的变化 0.402 -10.231 31.079 -58.287 -44.774
投资活动产生的现金 -71.078 2.11 380.756 -155.855 169.576
资本支出 -1.326 -1.221 -0.087 -0.07 -0.095
其他投资现金流量项目,总计 -69.752 3.331 380.843 -155.785 169.671
融资活动产生的现金 142.209 22.709 -147.636 -2.226 -2.244
股票的发行(报废),净额 93.341 34.409 68.944 -0.941 -0.24
债务的发行(退还),净额 48.868 -11.7 -216.58 -1.285 -2.004
现金净变化 -17.72 -62.198 90.151 -44.274 18.725
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -31.934 -101.944 -71.45 -48.063 -23.476
Cash From Operating Activities -31.613 -88.851 -67.282 -47.843 -23.421
Cash From Operating Activities 0.112 0.427 0.324 0.216 0.109
Non-Cash Items 3.68 12.264 8.648 5.783 2.797
Cash Interest Paid 1.556 2.289 1.281 0.634 0.085
Changes in Working Capital -3.471 0.402 -4.804 -5.779 -2.851
Cash From Investing Activities 12.093 -71.078 -95.252 -18.056 -4.408
Capital Expenditures -0.248 -1.326 -0.08 -0.076 -0.076
Other Investing Cash Flow Items, Total 12.341 -69.752 -95.172 -17.98 -4.332
Cash From Financing Activities -0.824 142.209 117.303 23.284 23.284
Issuance (Retirement) of Stock, Net -0.824 93.341 93.404 -0.864 -0.864
Issuance (Retirement) of Debt, Net 0 48.868 23.899 24.148 24.148
Net Change in Cash -20.344 -17.72 -45.231 -42.615 -4.545
Deferred Taxes
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Artal International S.C.A. Investment Advisor 45.506 86262020 0 2023-03-31 LOW
BVF Partners L.P. Hedge Fund 8.5192 16149179 0 2023-03-31 LOW
Ulys, L.L.C. Investment Advisor 2.7979 5303814 0 2022-08-01
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.792 5292626 43032 2023-03-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 2.7644 5240247 -11438 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.6709 5062976 -201281 2023-03-31 LOW
Invus Public Equities Advisors, LLC Investment Advisor 1.8549 3516214 0 2023-03-31 LOW
JP Morgan Asset Management Investment Advisor 1.6081 3048374 56229 2023-03-31 LOW
D. E. Shaw & Co., L.P. Hedge Fund 1.5515 2940997 -136976 2023-03-31 LOW
New Enterprise Associates (NEA) Venture Capital 1.2567 2382286 0 2023-03-31 LOW
Pinnacle Associates Ltd. Investment Advisor/Hedge Fund 1.0235 1940224 7447 2023-03-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9102 1725409 117468 2023-03-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.8251 1564098 47623 2023-03-31 LOW
Coats Lonnel Individual Investor 0.3927 744359 158356 2023-02-28 LOW
Fisher Investments Investment Advisor/Hedge Fund 0.38 720243 0 2023-03-31 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.3794 719182 306384 2023-03-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.3633 688611 -7329 2023-03-31 LOW
Parkman Healthcare Partners LLC Hedge Fund 0.3563 675328 254126 2023-03-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.3561 675018 -19915 2023-03-31 LOW
Asset Management One Co., Ltd. Investment Advisor/Hedge Fund 0.3194 605528 605528 2022-08-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

535K+

交易者

87K+

每月活跃客户

$113M+

每月投资额

$64M+

每月提取金额

交易计算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

交易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投资
交易规模(杠杆 x 投资):
開倉

平仓

做空 做多

Lexicon Company profile

关于 Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.是一家生物制药公司。 公司专注于发现、开发和商业化用于治疗人类疾病的药品。 其产品线包括Sotagliflozin、LX9211和LX2761。 Sotagliflozin是一种口服小分子化合物,正在开发用于治疗心衰和I型糖尿病,以及II型糖尿病、心衰和慢性肾脏病。 LX9211是一种口服的小分子化合物,正在开发用于治疗神经性疼痛。 公司正在进行LX9211治疗糖尿病周围神经痛的II期临床试验和LX9211治疗带状疱疹后神经痛的第二个II期临床试验。 LX2761是一种口服小分子化合物,设计用于在胃肠道局部抑制钠-葡萄糖共转运体1(SGLT1),而对肾脏的钠-葡萄糖共转运体2(SGLT2)没有任何抑制作用。

Industry: Bio Therapeutic Drugs

8800 Technology Forest Place
8800 Technology Forest Place
77381

收入报表

  • Annual
  • Quarterly

人们也观看

US100

14,557.80 Price
+0.640% 1D Chg, %
多头隔夜费 -0.0255%
空头隔夜费 0.0032%
隔夜费时间 21:00 (UTC)
价差 3.0

Oil - Crude

71.98 Price
+2.450% 1D Chg, %
多头隔夜费 -0.0201%
空头隔夜费 -0.0018%
隔夜费时间 21:00 (UTC)
价差 0.04

XRP/USD

0.54 Price
+3.470% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00485

BTC/USD

27,276.65 Price
+0.660% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

还在找一位您可以信任的经纪商吗?

加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易